These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 14620747

  • 1. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N, Ozer A, Topbas S, Yildirim N, Yurdakul S.
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [Abstract] [Full Text] [Related]

  • 2. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K, Greite JH, Bartenschlager EM.
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [Abstract] [Full Text] [Related]

  • 3. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
    Oficjalska-Młyńczak J, Marek J, Zajac-Pytrus H, Nizankowska MH, Koziorowska M.
    Klin Oczna; 1996 Mar; 98(6):423-5. PubMed ID: 9340414
    [Abstract] [Full Text] [Related]

  • 4. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D, Antohi I, Cionca D, Medvichi R, Cimpoeşu D.
    Oftalmologia; 2006 Mar; 50(2):68-72. PubMed ID: 16927762
    [Abstract] [Full Text] [Related]

  • 5. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
    Heiligenhaus A, Schilling H, Schilling M, Mellin KB.
    Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161
    [Abstract] [Full Text] [Related]

  • 6. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.
    Wu TT, Wang HH.
    Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882
    [Abstract] [Full Text] [Related]

  • 7. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
    Dotan A, Kaiserman I, Kremer I, Ehrlich R, Bahar I.
    Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.
    Ozveren F, Eltutar K.
    J Cataract Refract Surg; 2004 Aug; 30(8):1727-31. PubMed ID: 15313298
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
    Xie L, Li S, Dong X, Cao J, Shi W, Guo P.
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211
    [Abstract] [Full Text] [Related]

  • 10. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
    Zwaan J, Latimer WB.
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
    [Abstract] [Full Text] [Related]

  • 11. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
    Wedrich A, Menapace R, Ries E, Polzer I.
    J Cataract Refract Surg; 1997 Jun; 23(6):873-7. PubMed ID: 9292671
    [Abstract] [Full Text] [Related]

  • 12. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
    Siatiri H, Beheshtnezhad AH, Asghari H, Siatiri N, Moghimi S, Piri N.
    Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
    [Abstract] [Full Text] [Related]

  • 13. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
    Klais CM, Hattenbach LO, Steinkamp GW, Zubcov AA, Kohnen T.
    J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
    Zhao P, Wang W.
    Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
    [Abstract] [Full Text] [Related]

  • 15. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
    Burnstein Y, Higginbotham EJ.
    J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
    [No Abstract] [Full Text] [Related]

  • 16. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
    Wedrich A, Menapace R, Mühlbauer-Ries E.
    Int Ophthalmol; 1998 Oct; 18(5):277-80. PubMed ID: 7607808
    [Abstract] [Full Text] [Related]

  • 17. [Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator].
    Wollensak G, Meyer JH, Löffler KU, Funk J.
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):43-6. PubMed ID: 8965477
    [Abstract] [Full Text] [Related]

  • 18. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Georgiadis N, Boboridis K, Halvatzis N, Ziakas N, Moschou V.
    J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
    [Abstract] [Full Text] [Related]

  • 19. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F, Boehnke M.
    Ger J Ophthalmol; 1992 Apr; 1(5):354-60. PubMed ID: 1477641
    [Abstract] [Full Text] [Related]

  • 20. Intracameral tissue plasminogen activator to treat blocked glaucoma implants.
    Richards DW.
    Ophthalmic Surg; 1993 Dec; 24(12):854-5. PubMed ID: 8115105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.